Merz lands FDA approval for new use of muscle treatment; its N. American HQ is in Raleigh
“We designed our clinical trial program with 12 upper limb muscles to offer the most flexibility of any botulinum toxin, in order to offer patients, caregivers and doctors a safe and effective treatment option that meets the needs of pediatric patients,” says the firm’s CEO.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed